• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌三相CT扫描中肿瘤衰减及灌注参数的定量分析:与组织学分级的关系

Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.

作者信息

Pang Guodong, Shao Chunchun, Lv Yao, Zhao Fang

机构信息

Department of Radiology.

Department of Evidence-Based Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan.

出版信息

Medicine (Baltimore). 2021 Apr 23;100(16):e25627. doi: 10.1097/MD.0000000000025627.

DOI:10.1097/MD.0000000000025627
PMID:33879737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8078312/
Abstract

The aim of the current study was to explore the value of tumor attenuation and quantitative analysis of perfusion parameters obtained from traditional tri-phasic CT scans in grading hepatocellular carcinoma (HCC).Totally 39 patients (42 lesion samples) with pathologically confirmed HCC who underwent tri-phasic CT scans were enrolled. HCC lesions were divided into non-poorly differentiated HCC (NP-HCC; n = 31) and poorly differentiated HCC (pHCC; n = 11). All lesions were divided into 5 groups according to the attenuation on different CT enhancement phase. The values of tumor attenuation on different scanning phases were measured. The following parameters were calculated: arterial enhancement fraction (AEF), portal venous supply coefficient (PVC), and hepatic arterial supply coefficient (HAC). The relationship of perfusion parameters with the histological grade of HCC was analyzed. Receiver operating characteristic curves were generated.No significant correlation was observed between the perfusion parameters and tumor grading. Only HAC showed a non-significant trend in different grades of HCC (pHCC < NP-HCC; P = .07). The pHCC cases had significantly decreased values of tumor attenuation on the unenhanced phase (TAu), tumor attenuation on the portal phase portal phase (TAp), and equilibrium phase (TAe) (P < .01). The difference of tumor attenuation between the portal phase and the unenhanced phase (TAp-TAu) of the pHCC cases was decreased than that of the NP-HCC cases (P < .01), whereas the difference of attenuation between the equilibrium phase and portal phase (TAe-TAp) was significantly higher in the pHCC cases than that in the NP-HCC cases (P < .01). TAe-TAp had the highest area under the curve. The number of tumor enhancement pattern in Group 5 of HCCs with a diameter of 3 cm or more was significantly more than that of HCCs with a diameter of less than 3 cm or with other different enhancement patterns (P < .01).Histological HCC grading cannot be predicted by the perfusion parameters derived from traditional tri-phasic CT scans, whereas the tumor attenuation on different phases and the tumor attenuation differences among different phases, especially the mean value of TAe-TAp, might be useful for non-invasive prediction on the degree of HCC differentiation.

摘要

本研究的目的是探讨传统三期CT扫描获得的肿瘤衰减值及灌注参数定量分析在肝细胞癌(HCC)分级中的价值。共纳入39例经病理证实为HCC且接受过三期CT扫描的患者(42个病灶样本)。HCC病灶分为非低分化HCC(NP-HCC;n = 31)和低分化HCC(pHCC;n = 11)。所有病灶根据不同CT增强期的衰减情况分为5组。测量不同扫描期的肿瘤衰减值。计算以下参数:动脉增强分数(AEF)、门静脉供血系数(PVC)和肝动脉供血系数(HAC)。分析灌注参数与HCC组织学分级的关系。绘制受试者工作特征曲线。未观察到灌注参数与肿瘤分级之间存在显著相关性。仅HAC在不同分级的HCC中显示出不显著的趋势(pHCC < NP-HCC;P = 0.07)。pHCC病例在平扫期(TAu)、门静脉期(TAp)和平衡期(TAe)的肿瘤衰减值显著降低(P < 0.01)。pHCC病例门静脉期与平扫期的肿瘤衰减差值(TAp-TAu)低于NP-HCC病例(P < 0.01),而pHCC病例平衡期与门静脉期的衰减差值(TAe-TAp)显著高于NP-HCC病例(P < 0.01)。TAe-TAp的曲线下面积最大。直径≥3 cm的HCC第5组肿瘤强化模式的数量显著多于直径<3 cm或具有其他不同强化模式的HCC(P < 0.01)。传统三期CT扫描得出的灌注参数无法预测HCC的组织学分级,而不同期的肿瘤衰减值及不同期之间的肿瘤衰减差值,尤其是TAe-TAp的平均值,可能有助于对HCC分化程度进行无创预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/b7024ce0a9ee/medi-100-e25627-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/9eb5b16ce9cf/medi-100-e25627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/2312b48bc1bd/medi-100-e25627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/6df9735c9e8d/medi-100-e25627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/25e4b02c698f/medi-100-e25627-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/b7024ce0a9ee/medi-100-e25627-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/9eb5b16ce9cf/medi-100-e25627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/2312b48bc1bd/medi-100-e25627-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/6df9735c9e8d/medi-100-e25627-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/25e4b02c698f/medi-100-e25627-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc85/8078312/b7024ce0a9ee/medi-100-e25627-g005.jpg

相似文献

1
Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.肝细胞癌三相CT扫描中肿瘤衰减及灌注参数的定量分析:与组织学分级的关系
Medicine (Baltimore). 2021 Apr 23;100(16):e25627. doi: 10.1097/MD.0000000000025627.
2
Value of perfusion parameters and histogram analysis of triphasic computed tomography in pre-operative prediction of histological grade of hepatocellular carcinoma.三期 CT 灌注参数及直方图分析对肝癌术前病理分级的预测价值。
Chin Med J (Engl). 2021 Apr 14;134(10):1181-1190. doi: 10.1097/CM9.0000000000001446.
3
Value of perfusion parameters histogram analysis of triphasic CT in differentiating intrahepatic mass forming cholangiocarcinoma from hepatocellular carcinoma.三期 CT 灌注参数直方图分析鉴别肝内肿块型胆管细胞癌与肝细胞癌的价值。
Sci Rep. 2021 Nov 30;11(1):23163. doi: 10.1038/s41598-021-02667-4.
4
CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.CT 预测富血管型肝细胞癌的组织学分级:门脉期的作用。
Jpn J Radiol. 2013 Feb;31(2):89-98. doi: 10.1007/s11604-012-0149-5. Epub 2012 Oct 17.
5
Perfusion parameters of triphasic computed tomography hold preoperative prediction value for microvascular invasion in hepatocellular carcinoma.三期 CT 灌注参数对肝癌微血管侵犯有术前预测价值。
Sci Rep. 2023 May 27;13(1):8629. doi: 10.1038/s41598-023-35913-y.
6
Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans.基于三相CT扫描计算的肝动脉和门静脉血供系数对富血供肝脏病变进行分类。
J Digit Imaging. 2015 Apr;28(2):213-23. doi: 10.1007/s10278-014-9725-9.
7
Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.基于双期增强 CT 图像数据的纹理分析参数评价在药物洗脱微球经导管动脉化疗栓塞术(DEB-TACE)治疗肝细胞癌患者中的疗效预测:与肝灌注 CT 的相关性。
Acad Radiol. 2017 Nov;24(11):1352-1363. doi: 10.1016/j.acra.2017.05.006. Epub 2017 Jun 23.
8
Angiogenesis of hepatocellular carcinoma under multislice spiral CT plain scan and enhanced scan.多层螺旋CT平扫及增强扫描下肝细胞癌的血管生成
J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):895-903.
9
Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?使用钆塞酸增强磁共振成像(MRI)和灌注CT对肝细胞癌进行检测和特征描述的多参数成像:哪些参数效果最佳?
Cancer Imaging. 2017 Jun 28;17(1):18. doi: 10.1186/s40644-017-0121-9.
10
Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model.在大鼠肝脏模型中使用CT灌注技术从肝硬化中检测和鉴别早期肝细胞癌
Hepatobiliary Pancreat Dis Int. 2016 Dec;15(6):612-618. doi: 10.1016/s1499-3872(16)60148-0.

引用本文的文献

1
Predictive value of baseline CT imaging features combined with serum biomarkers for neoadjuvant chemotherapy response in adenocarcinoma of the gastroesophageal junction.基线CT影像特征联合血清生物标志物对胃食管交界腺癌新辅助化疗反应的预测价值
Am J Cancer Res. 2025 Apr 25;15(4):1955-1971. doi: 10.62347/XLSV6197. eCollection 2025.
2
A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.关于肝脏肿瘤中LI-RADS算法的叙述性综述:前景与陷阱
Diagnostics (Basel). 2022 Jul 7;12(7):1655. doi: 10.3390/diagnostics12071655.
3
Clinical and prognostic value of CT perfusion imaging parameters in patients with primary liver cancer after therapy.
CT灌注成像参数在原发性肝癌患者治疗后的临床及预后价值
Am J Transl Res. 2022 Jan 15;14(1):320-327. eCollection 2022.
4
Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.肝细胞癌的诊断评估与消融治疗评估
Infect Agent Cancer. 2021 Jul 19;16(1):53. doi: 10.1186/s13027-021-00393-0.